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Summary
Cancer patients are known to be highly susceptible to
Pseudomonas aeruginosa (Pa) infection, but it remains
unknown whether alterations at the tumor cell level can
contribute to infection. This study explored how cellular
changes associated with tumor metastasis influence Pa
infection using highly metastatic MTLn3 cells and non-
metastatic MTC cells as cell culture models. MTLn3 cells
were found to be more sensitive to Pa infection than MTC
cells based on increased translocation of the type III secretion
effector, ExoS, into MTLn3 cells. Subsequent studies found
that higher levels of ExoS translocation into MTLn3 cells
related to Pa entry and secretion of ExoS within MTLn3 cells,
rather than conventional ExoS translocation by external Pa.
ExoS includes both Rho GTPase activating protein (GAP)
and ADP-ribosyltransferase (ADPRT) enzyme activities, and
differences in MTLn3 and MTC cell responsiveness to ExoS
were found to relate to the targeting of ExoS-GAP activity to
Rho GTPases. MTLn3 cell migration is mediated by RhoA
activation at the leading edge, and inhibition of RhoA activity
decreased ExoS translocation into MTLn3 cells to levels
similar to those of MTC cells. The ability of Pa to be
internalized and transfer ExoS more efficiently in association
with Rho activation during tumor metastasis confirms that
alterations in cell migration that occur in conjunction with
tumor metastasis contribute to Pa infection in cancer
patients. This study also raises the possibility that Pa might
serve as a biological tool for dissecting or detecting cellular
alterations associated with tumor metastasis.
 2013. Published by TheCompany of Biologists Ltd. This is an
Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/
licenses/by/3.0), which permits unrestricted use, distribution
and reproduction in any medium provided that the original
work is properly attributed.
Key words: Tumor metastasis, MTC and MTLn3 cells, Pseudomonas
aeruginosa, Rho GTPase, Cell migration
Introduction
The relationship between bacterial infections and cancer is
complex. Bacteria, such as Helicobacter pylori, are a proven
carcinogen in the development of gastric cancer and mucosa-
associated lymphoid tissue lymphoma (Crowe, 2005; Montalban
et al., 2001). Other bacteria, such as Salmonella typhi,
Streptococcus bovis and Chlamydia pneumoniae have been
linked to the induction of specific types of cancers in
association with chronic infection, inflammation or immune
suppressive mechanisms (Dutta et al., 2000; Gold et al., 2004;
Koyi et al., 2001; Kuper et al., 2000). Bacteria and their toxins
have also been used to treat cancer. Coley’s vaccine, comprised
of live or heat-killed Streptococcus pyogenes and Serratia
marcescens, was historically used to limit many forms of
cancers, presumably by engaging an immune response that
protected against tumors (McCarthy, 2006). More recently,
modified bacteria, bacterial toxins and re-engineered
immunotoxins that target tumors or tumor-specific antigens
have been used clinically to preferentially kill tumor-associated
cells (Patyar et al., 2010). In addition to the role of bacteria in
tumor induction or treatment, physical and immunological
compromises associated with cancer or cancer treatments make
cancer patients highly susceptible to bacterial infection
(Benharroch and Osyntsov, 2012). Relationships between
bacterial infection and tumor induction introduce the notion
that there might be commonalities in mechanisms of bacterial
pathogenesis and tumor induction that can be applied to an
understanding of neoplastic processes.
Pseudomonas aeruginosa (Pa) is a Gram-negative,
predominantly extracellular, opportunistic pathogen that
frequently infects cancer patients. Pa maintains a broad range
of virulence factors that contribute to its pathogenicity, but
among these, the type III secretion (T3S) system is recognized to
be integral to the initiation of Pa infection and is associated with
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poor clinical outcomes (Hauser, 2009). The T3S system is a
needle-like nanostructure made by many Gram-negative bacteria
that allows the direct translocation of proteins or ‘effectors’ from
the bacterial cytosol to the host cell surface (Cornelis, 2010). T3S
effectors are then internalized into host cells through a bacterially
formed ‘translocon’ channel in eukaryotic cell membranes.
Within the cell, T3S effectors manipulate host cell function in
a bacterial specific manner to facilitate bacterial growth and
survival. The importance of T3S in the establishment of Pa
infection is supported by the findings that immunity induced
against the T3S translocon protein, PcrV, protects against Pa
infection, and that cellular susceptibility to Pa infection parallels
cellular sensitivity to T3S (Bridge et al., 2010; McGuffie et al.,
1999; Rucks and Olson, 2005; Sawa et al., 1999).
Pa utilizes T3S to disrupt normal host cell function and
promote infection through four identified effectors, ExoS, ExoT,
ExoU and ExoY. ExoS and ExoT are homologous, bifunctional
proteins that include Rho GTPase activating protein (GAP) and
ADP-ribosyltransferase (ADPRT) activities (Goehring et al.,
1999; Iglewski et al., 1978; Krall et al., 2000; Yahr et al., 1996).
The GAP activity of ExoS and ExoT functions in a similar
manner to inhibit host cell Rho family GTPase activity and alter
actin dynamics to prevent Pa internalization (Garrity-Ryan et al.,
2000). ExoS plays a more pronounced role in Pa pathogenesis
than ExoT (Shaver and Hauser, 2004), and this coincides with
ExoS-ADPRT activity having specificity for multiple cellular
proteins, including certain Ras family proteins (McGuffie et al.,
1998; Fraylick et al., 2002b; Henriksson et al., 2002), ERM
(ezrin, moesin and radixin) proteins (Maresso et al., 2004;
McGuffie et al., 1998), vimentin (Coburn et al., 1989), and
cyclophilin A (DiNovo et al., 2006). The substrate specificity of
ExoT-ADPRT activity in comparison is limited to Crk proteins
(Sun and Barbieri, 2003). ExoU has phospholipase A2 activity
that causes cell lysis and is associated with the most virulent Pa
infections (Sato et al., 2003; Shaver and Hauser, 2004). ExoY has
adenylate cyclase activity and appears to play a limited role in Pa
pathogenesis (Vance et al., 2005; Yahr et al., 1998).
Translocation of T3S effectors across host cell membranes is
the least understood stage in T3S but is known to require three
proteins in Pa: membrane channel forming PopB and PopD and
channel assembling PcrV (Mueller et al., 2008).
Examination of eukaryotic cell properties that influence T3S
translocation and responsiveness to ExoS found that most cell
lines were sensitive to ExoS toxicity, but different degrees of
toxicity were observed (McGuffie et al., 1999; Rucks et al.,
2003). Two cell lines, polarized confluent epithelial cells and
undifferentiated HL-60 promyelocytic cells, have been identified
to be resistant to Pa-T3S and ExoS toxicity (McGuffie et al.,
1999; Rucks et al., 2003; Rucks and Olson, 2005). Notably,
tumor-derived cell lines are generally highly sensitive to ExoS
toxicity (McGuffie et al., 1999). More recent studies of human
HT-29 colon and T24 bladder carcinoma cell lines identified a
relationship between the leading edge of migrating epithelial
cells and sensitivity to Pa-T3S and infection (Bridge et al., 2012;
Bridge et al., 2010). The finding that carcinoma derived cell lines
are highly sensitive to Pa-T3S and ExoS toxicity, while healthy
polarized epithelial monolayers are resistant to both, introduces
the possibility that responsiveness to ExoS toxicity might provide
insight into mechanistic properties linked to carcinogenesis.
The purpose of this study was to characterize properties of
carcinogenic cells that contribute to their increased sensitivity to
T3S translocated ExoS and the establishment of Pa infection.
Realizing the complexity of tumor development, this study
focused on two closely related tumor cell lines, MTC and MTLn3
cells. These cell lines were derived from subcutaneous
implantation of the rat mammary 13762 adenocarcinoma cell
line into Fisher 344 rats (Neri et al., 1982), but differ in that MTC
cells are non-metastatic and MTLn3 cells acquired high
metastatic potential. Based on the premise that cell migration
influences sensitivity to Pa infection, we examined whether
alterations in cell migration associated with tumor metastasis
might be a factor in influencing susceptibility to Pa infection.
Our studies found that ExoS was translocated more efficiently
into highly metastatic MTLn3 cells as compared to non-
metastatic MTC cells, consistent with tumor metastasis
enhancing sensitivity to Pa infection. When the mechanism
underlying differences in ExoS translocation between the two
cell lines was examined, increased ExoS translocation into
MTLn3 cells occurred in conjunction with increased Pa entry and
secretion of ExoS within MTLn3 cells. Rho activation is
increased at the leading edge of MTLn3 cells (El-Sibai et al.,
2007; El-Sibai et al., 2008), and inhibition of Rho activity in
MTLn3 cells decreased ExoS translocation to levels similar to
that of MTC cells. These are the first studies to demonstrate that
Rho activation in metastatic MTLn3 cells alters sensitivity to Pa
infection and mechanistically link alterations in cell migration
associated with tumor metastasis to increased sensitivity to Pa
infection.
Results
Highly metastatic MTLn3 cells allow greater Pa-T3S
translocation than non-metastatic MTC cells
To examine if tumor metastasis influenced sensitivity to Pa
infection, we compared the efficiency of Pa-T3S translocation
into non-metastatic MTC cells with that of highly metastatic
MTLn3 cells. Detection of Pa-T3S translocation into eukaryotic
cells requires a 1.5 to 3.5 hr co-culture period, depending on the
cell line and the method of analysis (Bridge et al., 2012; Bridge et
al., 2010). To adapt Pa co-culture conditions to studies of MTC
and MTLn3 cells, indicated infections were performed in
medium containing 5% FBS (steady state conditions) to allow
cells to move randomly during the co-culture period.
Examination of MTC and MTLn3 cell morphology under
steady state conditions found MTC cells to have an elongated
polarized morphology and a well-developed leading edge, typical
of mesenchymal migration (Fig. 1A). MTLn3 cells in
comparison were more rounded, lacked head-to-tail polarity,
and had a broad thin lamellar region demarcated by actin. These
morphological findings are similar to those previously observed
for MTC or MTLn3 cells following starvation and stimulation
with 5% serum (Shestakova et al., 1999), and document that
metastatic properties of MTC and MTLn3 cells correspond with
different migratory phenotypes.
To compare Pa-T3S translocation in MTC and MTLn3 cells,
sub-confluent monolayers were co-cultured with strain
PA103DUT expressing plasmid encoded HA-tagged wild type
ExoS (Pa ExoS-WT) for increasing times (0, 1.5 or 3 hr). T3S
translocation was assayed by monitoring ExoS effector transfer
into MTC or MTLn3 cell membrane fractions based on
immunoblot analysis, which was then quantified by
densitometry. As shown in Fig. 1B, no ExoS translocation was
detected in uninfected (0) cells or in either cell line after co-
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culture with Pa ExoS-WT for 1.5 hr. Following a 3 hr co-culture
period, ExoS translocation was detected in both cell lines, but
significantly (P,0.001) higher levels of ExoS translocation (4-
fold) were detected in MTLn3 cells as compared to MTC cells
(Fig. 1C). ExoS immunoblots were also probed for RalA, which
served as a membrane fraction loading control and is a substrate
of ExoS-ADPRT activity. RalA can be ADP-ribosylated by Pa
ExoS-WT at two to three sites, with Arg52 functioning as a
preferred site of ExoS ADP-ribosylation, and Arg135 and Arg161
functioning as secondary sites of ADP-ribosylation (Fraylick et
al., 2002a). ADP-ribosylation by ExoS causes RalA to shift in
mobility in a manner dependent on the number of sites of ADP-
ribosylation (Bridge et al., 2012; Fraylick et al., 2002a), and the
different shift in RalA mobility detected between MTC and
MTLn3 cells (Fig. 1B, noted by asterisks) can be explained by
RalA being ADP-ribosylated at more sites in MTC cells.
To assess if MTLn3 cells had enhanced Pa-T3S translocation
in general, duplicate immunoblots were probed for the T3S
translocon protein, PopB. Similar to ExoS, significantly
(P,0.05) more PopB was detected in the membrane fraction of
MTLn3 as compared to MTC cells after a 3 hr co-culture period
(Fig. 1B,C). Both cell lines remained .90% viable following co-
culture with Pa ExoS-WT, indicating that differences in T3S
translocation did not relate to ExoS cytotoxicity. T3S
translocation is dependent on Pa contact with eukaryotic cells,
but differences in T3S translocation did not relate to more
efficient Pa binding to MTLn3 cells, as an approximately equal
number of Pa (3.561.3 and 3.661.2) bound per MTLn3 and
MTC cell, respectively. Collectively these studies found that T3S
translocation was more efficient in metastatic MTLn3 cells than
non-metastatic MTC cells, and provided evidence that ExoS
ADP-ribosylation of RalA differed between the two cell lines.
Use of ExoS enzyme activity to characterize mechanisms
underlying differences in T3S translocation in MTC and MTLn3
cells
ExoS is a bi-functional T3S effector having N-terminal GAP
activity, defined by arginine residue 146 (R146), and C-terminal
ADPRT activity, defined by glutamic acid residues 379 and 381
(E379 and E381) (reviewed by Barbieri and Sun, 2004). Both
activities can alter ExoS translocation into eukaryotic cells (Aili
et al., 2008; Bridge et al., 2012; Cisz et al., 2008; Fraylick et al.,
2001). In turn, inactivation of ExoS-GAP or ADPRT activity has
proven useful in dissecting cellular mechanisms that underlie
T3S translocation and Pa infection (Bridge et al., 2012). To
determine if mutations that inactivate ExoS-GAP or ADPRT
activities might provide insight into mechanisms underlying
increased ExoS translocation into metastatic MTLn3 cells, MTC
and MTLn3 cells were co-cultured for 3 hr with strain
PA103DUT expressing plasmid encoded ExoS-HA with an
R146A mutation, ExoS-GAP(2), or E379A and E381A
mutations, ExoS-ADPRT(2). T3S translocation was assayed
based on ExoS and PopB transfer into membrane fractions by
immunoblot analysis, and this was compared with translocation
of Pa ExoS-WT, a Pa pUCP vector control, and uninfected cells.
As represented in Fig. 2A and quantified in 2B, inactivation of
ExoS-GAP activity significantly enhanced ExoS translocation
into both cell lines, as compared to Pa ExoS-WT, and allowed
ExoS translocation into MTC cells to closely approximate that of
MTLn3 cells. Inactivation of ExoS-ADPRT activity also caused a
modest, but significant (P,0.01) increase in ExoS translocation
into MTC cells when compared to Pa ExoS-WT (not noted in
Fig. 2B). The increase in ExoS translocation into MTLn3 cells
caused by inactivation of ExoS-ADPRT activity did not gain
statistical significance when compared to Pa ExoS-WT.
Comparisons between MTC and MTLn3 cells confirmed a
significant increase in translocation of ExoS-WT (P,0.001) and
ExoS-ADPRT(2) (P,0.01) into MTLn3 as compared to
translocation of the respective effectors in MTC cells. No
significant difference in ExoS-GAP(2) translocation was
detected between the two cells lines. Alterations in PopB
Fig. 1. Highly metastatic MTLn3 cells exhibit a different migratory
phenotype and allow greater Pa-T3S translocation than non-metastatic
MTC cells. (A) MTC and MTLn3 cell morphology was compared under steady
state conditions (5% FBS) in the absence of Pa. Cells were stained with
Phalloidin-TRITC to detect actin (white). Scale bar: 10 mm. (B) MTC and
MTLn3 cells were co-cultured with strain PA103DUT expressing plasmid
encoded HA tagged wild type ExoS (Pa ExoS-WT) for the indicated times.
Cells were harvested, fractionated and T3S translocation of ExoS and PopB into
membrane fractions was assayed by immunoblot analysis based on equal
protein loading. RalA modification served as a functional read-out of
translocated ExoS-ADPRT activity, and asterisks mark ADP-ribosylated RalA.
Total RalA served as a membrane fraction loading control. (sn) T3S induced Pa
ExoS-WT culture supernatant was used as a molecular marker for ExoS and
PopB. (C) T3S translocated ExoS and PopB were quantified by densitometry,
and significant differences in ExoS and PopB translocation between MTC and
MTLn3 cells are indicated. Results represent the mean 6 s.e.m. of five
independent experiments.
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translocation caused by inactivation of ExoS-GAP or ADPRT
activity generally paralleled alterations in ExoS translocation but
were less pronounced and did not gain statistical significance
(Fig. 2C). The Pa pUCP vector control included in this study
maintains a functional T3S system but lacks T3S effectors.
Consistent with these properties, PopB but not ExoS
translocation was detected following co-culture with Pa pUCP.
As in Fig. 1, alterations in ExoS translocation did not relate to
cytotoxic effects of Pa strains, and differences in the efficiency
of ExoS ADP-ribosylation of RalA were still evident between the
two cell lines (Fig. 2A).
The most important findings of these analyses were that: 1)
ExoS-GAP activity, and to lesser extent ExoS-ADPRT activity
interfered with ExoS translocation into MTC and MTLn3 cells,
indicating that ExoS was able to modulate T3S translocation by
two independent mechanisms. 2) Inactivation of ExoS-GAP
activity nullified differences in ExoS translocation between MTC
and MTLn3 cells, indicating that differences in ExoS
translocation between the two cells lines related to their
reactivity to ExoS-GAP activity. This led to our examining
whether ExoS-GAP activity might serve as a tool to further
characterize cellular differences that contribute to metastatic
properties of MTLn3 cells.
ExoS-GAP activity differentially alters MTC and MTLn3 cell
morphology
Effects of ExoS-GAP activity on MTC and MTLn3 cell function
were further examined by immunofluorescence microscopy (IF),
following co-culture with Pa expressing ExoS with active GAP,
Pa ExoS-WT or Pa ExoS-ADPRT(2), and compared with
alterations induced by Pa ExoS-GAP(2). MTC or MTLn3 cell
morphology was examined after a 1 hr 45 min co-culture period,
which was previously found to allow detection of low levels of
ExoS translocation by IF, while limiting toxic effects of ExoS on
cell morphology (Bridge et al., 2012). Following co-culture, cells
were stained for extracellular or intracellular Pa, HA to detect
ExoS effector translocation, and actin to detect alterations in
cytoskeletal structure.
Distinctly different alterations in MTC and MTLn3 cell
morphology were observed following co-culture with Pa
expressing ExoS-WT (Fig. 3A,B, ExoS-WT panels).
Translocation of ExoS-WT caused MTC cells to contract and
leading edge architecture was replaced with branched actin
filaments that remained adherent to cell matrix. Translocation of
ExoS-WT into MTLn3 cells caused loss of actin demarcation of
the lamellipodium, and instead actin-spiked projections protruded
from within the lamellipodium. Pa expressing ExoS-WT was
also internalized more efficiently into MTLn3 cells than MTC
cells. Consistent with Pa ExoS-WT and Pa ExoS-ADPRT(2)
both having GAP activity, morphological alterations caused by
these two strains were similar. As with Pa ExoS-WT, Pa ExoS-
ADPRT(2) caused MTC cells to contract, while branched actin
filaments remained adherent cell matrix (Fig. 3A, ExoS-
ADPRT(2) panels). In MTLn3 cells, Pa ExoS-ADPRT(2)
caused actin-spiked projections to protrude from within the
lamellipodium, similar to that observed in response to Pa ExoS-
WT (Fig. 3B, ExoS-ADPRT(2) panels).
Inactivation of ExoS-GAP activity led to somewhat similar
morphological outcomes in MTC and MTLn3 cells. Long, non-
branching actin filaments projected from the lamellipodium of
MTC cells in response to Pa ExoS-GAP(2), while the cells
retained their same general morphological shape (Fig. 3A, ExoS-
GAP(2) panels). Long actin filaments were also observed to
project from the lamellipodium of MTLn3 cells in response to Pa
ExoS-GAP(2), but the leading edge of MTLn3 cells often
became distorted, as observed in Fig. 3B, ExoS-GAP(2) panels.
Inactivation of ExoS-GAP increased Pa internalization into both
MTC and MTLn3 cells, and this was accompanied by detection
of ExoS-GAP(2) effector secretion by internalized Pa in both
cell lines (Fig. 3A,B, enlarged ExoS-GAP(2) panels, marked by
Fig. 2. ExoS-GAP activity determines differences in T3S translocation in
MTC and MTLn3 cells. (A) MTC and MTLn3 cells were co-cultured for 3 hr
with Pa ExoS-WT, Pa expressing ExoS with a R146A GAP(2) mutant, or Pa
expressing ExoS with an E379A and E381A ADPRT(2) mutant. Controls
include uninfected cells (0) or cells co-cultured with a Pa pUCP plasmid
control. Cells were harvested, fractionated and T3S translocation of ExoS and
PopB into membrane fractions was assayed as in Fig. 1. (B) T3S translocated
ExoS following co-culture with the indicated Pa strain was quantified by
densitometry, and the mean 6 s.e.m. of three independent experiments are
represented. Significant differences between MTC and MTLn3 translocation of
ExoS-WT and ExoS-ADPRT(2) are indicated. No significant difference in
ExoS-GAP(2) translocation between MTC and MTLn3 cells was observed.
Asterisks mark significant differences in ExoS-WT and ExoS-GAP(2)
translocation into MTC cells (**P,0.001), or in ExoS-WT and ExoS-GAP(2)
translocation into MTLn3 cells (*P,0.01). A significant (P,0.01) increase in
translocation of ExoS-ADPRT(2) as compared to ExoS-WT was also detected
in MTC cells, which is not indicated in Fig. 2B for simplicity. (C) T3S
translocated PopB following co-culture with the indicated Pa strain was
quantified by densitometry, and the mean 6 s.e.m. of three independent
experiments are represented. Differences observed in PopB translocation did
not gain statistical significance.
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blue arrows). In summary, MTC and MTLn3 cells responded
differently to Pa when ExoS-GAP was active but produced
similar morphological outcomes when ExoS-GAP was inactive.
The most severe morphological alterations caused by ExoS-GAP
in both cell lines were alterations in actin organization affecting
leading edge or lamellipodium architecture. These results are
consistent with ExoS-GAP activity responding to differences in
migratory properties of non-metastatic MTC and metastatic
MTLn3 cells.
Metastatic properties of MTLn3 cells enhance Pa internalization
The observation that Pa internalization was enhanced in
association with increased ExoS translocation into MTLn3 cells
led to our examination of the relationship between Pa
internalization and ExoS translocation. Pa internalization into
MTC or MTLn3 cells was visually enumerated, using IF staining
and microscopy to identify intracellular Pa, in four independent
experiments, where co-culture times ranged from 1 hr 45 min to
3 hr (Fig. 4A). Fig. 4B is included to allow direct comparisons of
ExoS translocation based on immunoblot analysis with Pa
internalization. Pa expressing ExoS-WT were internalized into
MTLn3 cells 5-fold more efficiently than into MTC cells
(P,0.01), and this corresponded with a 4.4-fold increase in
ExoS-WT translocation into MTLn3 cells than MTC cells. When
ExoS-GAP activity was inactivated, Pa internalization increased
20-fold (P,0.001) in MTC cells and 4-fold in MTLn3 cells
(P,0.01), when compared to Pa ExoS-WT, essentially
eliminating differences in Pa internalization between the two
cell lines (Fig. 4A). No significant differences in Pa
internalization were observed in either cell line between Pa
ExoS-WT and Pa ExoS-ADPRT(2). Collectively, when Pa
internalization and ExoS translocation were compared in MTC
and MTLn3 cells following treatment with Pa ExoS-WT, Pa
ExoS-GAP(2) or Pa ExoS-ADPRT(2) (comparisons of data
represented in Fig. 4A,B) a positive (r50.96) correlation was
observed, indicating that the efficiency of ExoS transfer into
MTC and MTLn3 cells directly correlated with the efficiency of
Pa internalization.
IF analysis of ExoS translocation into MTC and MTLn3 cells
following a 3 hr co-culture found ExoS effector staining to be
more intense in both cell lines (Fig. 4C,D), as compared to a 1 hr
45 min co-culture time in Fig. 3. Cells in general also became
more rounded after the longer co-culture time. In MTC cells
effector staining was observed to align with branched actin
filaments that remained adherent to the cell matrix as cells
contracted in response to Pa ExoS-WT or Pa ExoS-ADPRT(2)
(Fig. 4C, insets show enlargement of ExoS-WT and ExoS-
ADPRT(2) effector alignment with actin). Alignment of ExoS-
WT or ExoS-ADPRT(2) effector with actin was not evident in
MTLn3 cells, rather effector was diffusely distributed within the
cell. Consistent with immunoblot analysis (Fig. 2A) effector
staining reached highest intensity in both MTC and MTLn3 cells
following co-culture with Pa ExoS-GAP(2) and was both diffuse
within the cell and in close association with internalized Pa
Fig. 3. ExoS-GAP activity differentially alters MTC
and MTLn3 cell morphology. (A) MTC or (B) MTLn3
cells were co-cultured for 1 hr 45 min with Pa expressing
active GA, ExoS-WT or ExoS-ADPRT(2); inactive GAP,
Pa ExoS-GAP(2); or with no Pa (0). Following co-culture
cells were stained for extracellular Pa (yellow + pink), then
fixed and permeabilized and stained for intracellular Pa
(pink). ExoS effector was detected using an anti-HA
antibody (green), and F-actin was stained using phalloidin
(white). Scale bars: 10 mm. Regions of images enclosed in
boxes were enlarged to allow better visualization of
alterations in actin leading edge architecture following co-
culture with Pa expressing the indicated ExoS effector. In
enlarged images, intracellular Pa are indicated with yellow
arrows, and intracellular Pa secreting ExoS effector are
indicated with blue arrows. Results are representative of
four independent experiments.
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(Fig. 4C,D, ExoS-GAP(2) panels; intracellular Pa are marked by
yellow arrows, insets show enlargement of close association of
ExoS-GAP(2) effector with Pa). These studies provide further
evidence that increased ExoS translocation into MTLn3 cells
relates to Pa internalization and secretion of ExoS within cells,
and that inactivation of ExoS-GAP equilibrates ExoS
translocation in MTC and MTLn3 cells in conjunction with
increased Pa internalization. The finding that ExoS-WT is
secreted by internalized Pa within MTLn3 cells, whereas ExoS-
WT is predominately T3S translocated into MTC cells by
external Pa, also provides an explanation for the more efficient
ADP-ribosylation of RalA in MTC cells, as ExoS would have an
opportunity to gain access to membrane associated RalA during
the T3S translocation process.
Characterization of the target of ExoS-GAP activity that
differentiates Pa infection in MTC and MTLn3 cells
ExoS-GAP activity targets Rho GTPases that regulate actin
polymerization required for membrane protrusion during cell
migration. MTLn3 cell motility has been well studied and differs
from mesenchymal migration of most epithelial cells by the
localization of RhoA, rather than Rac1, to protruding edges of
migrating cells (El-Sibai et al., 2008). Rho and Rac activation are
reciprocally balanced within cells during migration and
determine whether tumor cells move in an amoeboid or
mesenchymal manner (Sander et al., 1999; Sanz-Moreno et al.,
2008). To test whether Rho activity defines the property that
differentiates Pa infection in MTLn3 and MTC cells, ExoS
translocation was monitored following treatment of both cell
lines with Y-27632, an inhibitor of p160 Rho associated protein
kinase (ROCK), which is a major downstream effector of Rho
GTPase activity associated with tumor invasion (de Toledo et al.,
2012). In this regard, previous studies in MTLn3 cells found that
inhibition of either Rho GTPase or ROCK (Rho/ROCK) activity
led to the reciprocal activation and localization of Rac1 to newly
formed protrusions in MTLn3 cells (El-Sibai et al., 2008). As a
control, both cell lines were treated with NSC23766, a Rac1
inhibitor, which is predicted to have no effect on T3S
translocation in MTLn3 cells.
In ROCK inhibition studies, MTC and MTLn3 cells were
starved for 3 hr prior to the addition of 25 mM ROCK inhibitor,
Y-27632, for 30 min. Phase contrast images show that treatment
with ROCK inhibitor for 30 min caused severe contraction of
MTC cell morphology. MTLn3 cells in comparison became more
elongated in the presence of ROCK inhibitor, with the trailing
edge becoming severely contracted. Following treatment with
ROCK inhibitor, cells were either uninfected or co-cultured for
3.5 hr with Pa ExoS-WT, Pa ExoS-GAP(2), or Pa ExoS-
ADPRT(2) in the presence of inhibitor under steady-state
conditions. When ExoS translocation was assayed in MTC cells
following treatment with ROCK inhibitor, no significant
alteration in the ExoS translocation pattern was detected
following co-culture with Pa ExoS strains as compared with
non-ROCK inhibitor treated cells (Fig. 5B). In contrast,
Fig. 4. Metastatic properties of MTLn3 cells
enhance Pa internalization. (A) MTC and
MTLn3 cells were co-cultured for 1 hr 45 min to
3 hr in four independent experiments with Pa
ExoS-WT, Pa ExoS-GAP(2) or Pa ExoS-
ADPRT(2). Cells were stained for extracellular
or intracellular Pa as in Fig. 3, and Pa
internalization was visually enumerated based
on Pa association with an average of 140 MTC
or MTLn3 cells per strain. Results are expressed
as the mean 6 s.e.m. of Pa internalized per
MTC or MTLn3 cell. Significant difference
(P,0.01) in Pa ExoS-WT internalization in
MTC and MTLn3 is indicated. Asterisks mark
significant differences in Pa ExoS-WT and Pa
ExoS-GAP(2) internalization in MTC cells
(**P,0.001) or Pa ExoS-WT and Pa ExoS-
GAP(2) internalization in MTLn3 cells
(*P,0.01). (B) Compares ExoS data shown in
Fig. 2B with Pa internalization data (A).
Significant differences are indicated. (C) MTC
and (D) MTLn3 cells were uninfected (0) or co-
cultured for 3 hr with Pa ExoS-WT, Pa ExoS-
GAP(2) or Pa ExoS-ADPRT(2). Cells were
stained as in Fig. 3 for extracellular Pa (yellow
+ pink), intracellular Pa (pink, indicated with
yellow arrows), ExoS effector (green), and actin
(white). Insets show enlargement of regions
where ExoS effector co-localizes with actin
(MTC cells: ExoS-WT or ExoS-ADPRT(2)
images), or where ExoS effector co-localizes
with intracellular Pa (ExoS-GAP(2): MTC and
MTLn3 cell images). Scale bars: 10 mm. Results
are representative of four independent
experiments, but images from a single
experiment are compared in panels C and D.
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treatment of MTLn3 cells with ROCK inhibitor caused a
significant decrease in translocation by Pa ExoS-WT
(P,0.003) and Pa ExoS-ADPRT(2) (P,0.002), while causing
no significant alteration in Pa ExoS-GAP(2) translocation.
Myosin II regulatory light chain (RLC) is one of several
substrates phosphorylated by ROCK, and when RLC
phosphorylation was used to assess inhibition of ROCK activity
by Y-27632, a decrease in both mono- (P1) and di-
phosphorylated (P2) RLC were detected in cell lysates
following treatment of MTC or MTLn3 cells with ROCK
inhibitor and co-culture with Pa strains (Fig. 5B). Alternatively,
when both cell lines were starved for three hours, and then treated
with 50 mM NSC23766 for 12–16 hr to inhibit Rac1 activity
prior to co-culture with Pa strains, no significant alteration in
ExoS translocation in either MTC or MTLn3 cells was detected
(data not shown). In summary, these experiments found that
treatment of MTLn3 cells with ROCK inhibitor altered their
ExoS translocation pattern to one similar to that of MTC cells,
while treatment of MTC cells with ROCK inhibitor, or treatment
of both cell lines with Rac1 inhibitor, caused no significant
alterations in ExoS translocation. Collectively our results are
consistent with activation of Rho/ROCK, but not Rac1, mediating
increased translocation of ExoS-WT in highly metastatic MTLn3
cells, and highlight the ability of Pa ExoS-GAP activity to
function as a biological probe to detect alterations in MTLn3 cell
properties linked to metastasis.
Discussion
The high susceptibility of cancer patients to P. aeruginosa
infections is generally attributed to immunosuppression and
systemic compromises associated with cancer treatments. As a
result, the possibility that alterations at the tumor cell level might
contribute to Pa infection remains relatively unexplored. In
focusing on how metastatic properties of tumor cells might
influence Pa infection, we found that ExoS translocation was
more efficient in highly metastatic MTLn3 cells as compared to
Fig. 5. Inhibition of ROCK activity inMTLn3 cells decreased ExoS translocation. (A) MTC and MTLn3 cell morphology was examined by phase contrast microscopy
following no treatment (0), serum starvation for 3 hr and treatment for 30 min with DMSO (control), or serum starvation and treatment for 30 min with 25 mM Y-27632.
MTC cells severely contracted in response to ROCK inhibitor, while MTLn3 cells adapted an elongated morphology with a severely contracted trailing edge. Images were
taken at 206magnification. (B) Following treatment with ROCK inhibitor, MTC and MTLn3 cells were either uninfected (0) or co-cultured for 3.5 hr with Pa ExoS-WT,
Pa ExoS-GAP(2) or Pa ExoS-ADPRT(2) under steady state conditions. Cells were washed, detached with trypsin, resuspended in Laemmli buffer, and ExoS translocation
was examined by SDS-11%PAGE analysis based on equal protein loading. RalA modification served as a functional read-out of translocated ExoS-ADPRT activity,
and is indicated by an asterisk. GAPDH served as a whole cell lysate protein loading control. Below line, samples were re-analyzed by SDS-14%PAGE based on equal
protein and immunoblotted for mono- (P1) or di- (P2) phosphorylated myosin II regulatory light chain (RLC) to assess inhibition of ROCK activity by Y-27632. (C) T3S
translocated ExoS was quantified by densitometry, and the mean 6 s.e.m. of three independent experiments are represented. Significant differences in ExoS translocation
following treatment of MTLn3 cells with ROCK inhibitor and co-culture with Pa ExoS-WT or Pa ExoS-ADPRT(2) are indicated.
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non-metastatic MTC cells. Pa is primarily an extracellular
pathogen, but further analysis revealed that increased ExoS
translocation into MTLn3 cells directly correlated with Pa
internalization and secretion of ExoS within MTLn3 cells, which
contrasts with conventional T3S translocation by extracellular Pa
through a T3S membrane translocon channel. Differences in
MTLn3 and MTC cell responsiveness to Pa ExoS related to
reactivity to ExoS-GAP activity. In turn, inactivation of ExoS-
GAP by an R146A mutation eliminated differences in the
susceptibility of MTC and MTLn3 cell to Pa infection as
assessed based on ExoS translocation and Pa internalization.
ExoS-GAP activity targets Rho family proteins, and inhibition of
ROCK activity, a downstream effector of Rho GTPase activity
associated with tumor invasion (de Toledo et al., 2012),
significantly decreased ExoS translocation into MTLn3 cells.
The finding that Rho/ROCK signaling in MTLn3 cells enhanced
Pa internalization, and that this resulted in increased ExoS
transfer into MTLn3 cells identifies one property of metastatic
tumor cells that can alter sensitivity to Pa infection.
The ability of Pa-ExoS to differentially infect MTC and
MTLn3 cells based on their metastatic properties introduces the
interesting possibility that reactivity to Pa ExoS might serve as a
tool to predict or detect the metastatic potential of neoplastic
tissue. Tumor progression to metastasis is a complex process that
involves modulations of cell adhesion, migration, and
extracellular matrix (Struckhoff et al., 2011). This complexity
has complicated detection and delineation of the metastatic
processes. The possibility that Pa ExoS can serve as a tool for
assessing the metastatic potential of tumors is predicated on the
ability of Pa to infect migrating (invasive) cells, and the ability of
ExoS to target eukaryotic cell proteins that mediate tumor
progression and metastasis, including Rho-GTPases, Ras family
proteins, ERM proteins, vimentin and cyclophilin A (Struckhoff
et al., 2011; Bos, 1988; Curto and McClatchey, 2004; Lee and
Kim, 2010; Satelli and Li, 2011). Interestingly, the focus of this
study became ExoS-GAP activity, which served as a functional
probe to differentiate Rho GTPase activity in MTC and MTLn3
cells. Previous studies comparing Rac and Rho activity in MTC
and MTLn3 cells found MTC cells to have decreased RhoA
activity, increased Rac activity and to utilize Rac to produce
membrane protrusions that mediate cell migration (El-Sibai et al.,
2008). MTLn3 cells in comparison were characterized as having
increased RhoA activity, decreased Rac activity, and to project
Cdc42 mediated membranes protrusions during cell migration
(El-Sibai et al., 2007; Yip et al., 2007). Notably, the phenotype of
Rho/ROCK activation at the leading edge of MTLn3 cells could
be switched to Rac1 driving cell protrusion by treatment with a
ROCK inhibitor (El-Sibai et al., 2008), just as the phenotype of
enhanced ExoS translocation in MTLn3 cells could be switched
to low ExoS translocation by treatment with a ROCK inhibitor.
The finding that Pa infection and ExoS translocation can
differentiate Rac1 (non-metastatic) or RhoA (metastatic)
properties of MTC or MTLn3 cells, and detect the reversal of
these properties following treatment with ROCK inhibitor, draws
attention parallels between Pa infection and tumor metastasis.
Evidence that Pa ExoS-GAP activity can discriminate
differences in Rho GTPases in tumor cells, beyond Rho or Rac
activation, was provided by IF studies, which found MTC cells to
contract but retain stably adhered branched actin filaments in
response to Pa ExoS-GAP, which contrasted with the response of
MTLn3 cells, where leading edge architecture was replaced with
actin microspikes. The precise mechanisms underlying
morphological differences in MTC and MTLn3 cell
responsiveness to ExoS-GAP activity remain unknown, but
they identify previously unrecognized differences in adhesion
properties of MTC and MTLn3 cells, which might prove
applicable to diagnosis of metastatic tumors.
The possibility that Pa-ExoS might also serve as a biological
probe to dissect cellular mechanisms that underlie tumor
metastasis is founded on interesting similarities between Pa
infection and tumor development. For example, the finding that
increased levels of ExoS transfer into metastatic MTLn3 cells
related to Pa internalization draws attention to relationships
between membrane properties that facilitate Pa internalization
and those associated with tumor metastasis. Pa is predominately
an extracellular pathogen, and susceptibility to infection and Pa
internalization is influenced by epithelium integrity and polarity
(Fleiszig et al., 1997; Plotkowski et al., 1999). In studies of
MDCK epithelial cells, Pa internalization was enhanced in
incompletely polarized monolayers in association with RhoA
activation and decreased in highly polarized monolayers in
conjunction with Cdc42 activation (Kazmierczak et al., 2004). In
our studies, inhibition of ROCK activity significantly decreased
ExoS translocation into MTLn3 cells, consistent with Rho/ROCK
activation mediating enhanced Pa internalization in MTLn3
cells. Rho/ROCK signaling also mediates amoeboid migration
and membrane blebbing that enhance tumor cell invasiveness
(Struckhoff et al., 2011). The possibility that membrane blebbing
might be a common basis for Pa internalization and tumor
metastasis is supported by a recent study that identified the ability
of Pa to enter, survive and replicate within membrane blebs of
corneal epithelial cells, in an ExoS-ADPRT dependent manner
(Angus et al., 2010). Membrane blebbing is a rapid, dynamic
process, and a core element in bleb formation is retraction of the
plasma membrane, which is mediated by signaling through Rho/
ROCK and actinomycin contractility (Charras and Paluch, 2008).
Thus, comparisons of tumor metastasis with Pa internalization
find that both processes are facilitated by Rho/ROCK activation
and by membrane bleb formation. The possibility that Rho/
ROCK mediated membrane blebs might contribute to Pa
internalization in MTLn3 cells is supported by the detection of
blebbing in MTLn3 cells, but not MTC cells, following infection
of with Pa ExoS-GAP(2) that maintains ExoS-ADPRT activity
(supplementary material Fig. S1). Functional similarities between
membrane blebs that mediate bacterial internalization and tumor
metastasis have not previously been realized, and awareness of
these similarities provides a new perspective on alterations in
membrane properties that occur in association with tumor
metastasis.
To summarize, in using metastatic MTLn3 cells and non-
metastatic MTC cells as cell culture models to study Pa infection
we were able to confirm that alterations at the tumor cell level
can contribute to the establishment of Pa infection.
Mechanistically enhanced Pa infection in MTLn3 cells related
to Rho/ROCK activation, which drives cell migration and
membrane plasticity during tumor cell invasion, and also
facilitates Pa internalization. This is the first study to
characterize a mechanism underlying the increased
susceptibility of cancer patients to Pa infection at the cellular
level. Reactivity to T3S translocated ExoS also allowed
recognition of functional differences in Rho GTPase activity
between MTC and MTLn3 cells that extend beyond Rac1 and
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Rho activation. Notably, commonalities observed between tumor
development and Pa infection, along with the finding that
reactivity to Pa ExoS can differentiate non-metastatic and
metastatic properties of MTC and MTLn3 cells, introduces the
notion that Pa ExoS might serve as a biological tool to assess the
metastatic properties of neoplastic tissue. While further studies
are required to determine how Pa ExoS will respond to different
tumorigenic states, the ability of ExoS to target and alter the
function of multiple tumor-associated proteins provides the
diversity needed accommodate tumor heterogeneity.
Materials and Methods
Bacterial strains
P. aeruginosa strain PA103DUT is T3S effector-less derivative of strain PA103
that maintains an intact T3S system (Vallis et al., 1999). This strain was used to
express: 1) plasmid encoded HA-tagged wild type ExoS, 2) ExoS with mutations
that inactivate its GAP or ADPRT activities, or 3) a pUCP vector control, as
previously described (Bridge et al., 2012). Pa strains were grown in ExoS
induction medium (Iglewski et al., 1978) for 14–16 hr and were washed twice in
cell culture medium prior to infection of eukaryotic cells.
Eukaryotic cell culture
Rat mammary adenocarcinoma MTLn3 and MTC cell lines were obtained from
John Condeelis (Albert Einstein College of Medicine, Bronx NY) and Jonathan
Backer (Albert Einstein College of Medicine), respectively. Both cell lines were
cultured in Minimal Essential Medium, Alpha (MEM; Cellgro, Manassas VA),
containing nonessential amino acids (Cellgro), 10% fetal bovine serum (FBS;
Hyclone, Logan UT), 100 U/ml penicillin, and 100 mg/ml streptomycin (Hyclone).
Analysis of Pa-T3S translocation
Pa-T3S translocation was assayed by monitoring transfer of the T3S effector,
ExoS, and T3S translocon protein, PopB, into membrane fractions following co-
culture with Pa strains. For these analyses, MTC and MTLn3 cells were seeded at
26104 and 2.56104 cells/ml, respectively, in 60 mm dishes (Corning Inc., Corning,
NY) and grown for 48 hr. Prior to addition of bacteria, cells were washed with
Dulbecco’s phosphate buffered saline (DPBS; Hyclone) and starved for 3–12 hr in
MEM containing 0.35% bovine serum albumin (BSA; Sigma–Aldrich, St. Louis
MO) and 12 mM HEPES (pH 7.4) (starvation medium). T3S translocation was
analyzed following co-culture of MTC and MTLn3 cells for 0 to 3.5 hr with
107 CFU/ml Pa in MEM containing 0.6% BSA. Following co-culture, bacteria
were removed, cells were washed twice with DPBS containing 200 mg/ml
ciprofloxacin, and then incubated with 0.25% trypsin–1 mM EDTA (Hyclone) to
detach cells and degrade extracellular proteins. An aliquot of cells was removed
and assayed for viability using trypan blue staining. Cells were washed with DPBS
and fractionated as previously described (Rocha et al., 2005). An aliquot of the
membrane fraction was removed and analyzed for total protein (BCA Protein
Assay; Pierce, Rockville IL). Transfer of ExoS and PopB into membrane fractions
was determined by SDS-PAGE and immunoblot analysis, based on equal protein
loading. Protein bands were quantified by densitometry analysis of immunoblots
using ImageJ 1.40 g software (http://rsbweb.nih.gov/ij), as previously described
(Bridge et al., 2010; Fraylick et al., 2001). RalA served as a membrane fraction
loading control, and ADP-ribosylation of RalA provided a functional assay of T3S
translocated ExoS-ADPRT activity (Fraylick et al., 2002a). Antibodies used for
immunoblot analysis included: anti-HA (Covance Research, Princeton NJ) to
detect HA-tagged ExoS effectors, anti-PopB (provided by Joseph Barbieri,
Medical College of Wisconsin, Milwaukee, WI), and anti-RalA (BD-Transduction,
San Jose CA).
To visualize T3S effector translocation and Pa internalization by IF microscopy,
MTC and MTLn3 cells were seeded at 2.46104 cells/ml in chamber slides (Nalge
Nunc International, Rochester NY) for 24 and 48 hr, respectively. Cells were
starved for 3 hr and co-cultured for 0 to 3 hr with 107 CFU/ml Pa in MEM
containing 5% FBS (steady state conditions) (El-Sibai et al., 2008; Shestakova et
al., 1999). Following co-culture, cells were washed twice in DPBS and processed
for IF analysis, as previously described (Bridge et al., 2012; Bridge et al., 2010).
Briefly, external Pa were stained using anti-Pa LPS (obtained from Joseph Lam,
University of Guelph, Guelph, Ontario) and visualized using a Qdot 655 goat anti-
rabbit conjugate (Invitrogen). Cells were then fixed, permeabilized, blocked, and
both intracellular and extracellular Pa were stained with anti-Pa LPS followed by
an Alexa Fluor 647 conjugate (Invitrogen) (Bridge et al., 2012). Internal Pa were
differentiated by the absence of Qdot 655 staining. Intracellular or extracellular
bacterial localization was visually enumerated. HA-tagged ExoS effectors were
detected using anti-HA and an anti-mouse Alexa Fluor 488 conjugate. F-actin was
detected using Phalloidin-TRITC (Sigma–Aldrich). Images were examined using a
Plan-Apochromat 636/1.40 oil objective on a Zeiss Imager.Z1 LSM 510 confocal
microscope (Jena, Germany) and exported to Adobe Photoshop CS4 Extended
(Adobe Systems Inc., San Jose, CA) as 8 bit TIFF files. Channels in IF images
were pseudocolored as indicated to improve visibility.
Inhibition Rho and Rac activity
To assess the role of Rho and Rac in Pa-T3S translocation, MTC and MTLn3 cells
were seeded in 60 mm dishes, as described above, and starved for 3 hr prior to
addition of inhibitors. Rho activity was inhibited by treating cells for 30 min in
starvation medium with 25 mM Y-27632 (Cayman Chemical Company, Ann
Arbor, MI), an inhibitor of p160 Rho associated protein kinase (ROCK), which is a
downstream effector of Rho GTPase activity known to influence cell invasion (de
Toledo et al., 2012). Rac1 activity was inhibited by treating cells for 12–16 hr with
50 mM NSC23766 (EMD Chemicals, Gibbstown, NJ) in starvation medium.
Effects of the drugs on cell morphology were visualized with a LD A-Plan 206/0.3
Ph1 objective on a Zeiss Axiovert 200 microscope (Jena, Germany). Images were
exported to Adobe Photoshop CS4 Extended (Adobe Systems Inc.) as TIFF files
and cropped.
Following treatment with inhibitor, cells were co-cultured with Pa strains for
3.5 hr in the presence of inhibitor in MEM containing 5% FBS. Cells were then
washed twice with DPBS containing 200 mg/ml ciprofloxacin and detached with
trypsin. An aliquot of cells was lysed and analyzed for total protein (BCA Protein
Assay, Pierce). Remaining cells were resuspended in DPBS containing
ciprofloxacin and lysed in Laemmli sample buffer. Whole cell lysates were
analysed by SDS-11% PAGE and immunoblot analysis as above, using anti-HA to
detect T3S translocated ExoS effectors, anti-RalA to assess T3S translocated
ExoS-ADPRT activity, and anti-glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) (Millipore, Temecula CA) to monitor protein loading of whole cell
lysates. To detect inhibition of ROCK activity by Y-27632 in conjunction with
alterations in ExoS translocation, whole cell lysates were re-analyzed by SDS-14%
PAGE, and myosin II light chain phosphorylation was detected using an affinity
purified rabbit anti-phospho Thr18/Ser19 RLC antibody (Chew et al., 1998). ExoS
effector translocation was quantified by densitometry using ImageJ 1.40 g
software.
Statistical analysis
JMP Version 9 Software (SAS Institute, Cary, NC) was used for statistical
analysis, and significance was determined by a two-sided alpha level set at
P,0.05. One-way ANOVAs were used to evaluate differences among Pa strains
between cell lines. Multiple comparisons were analyzed with a Tukey’s HSD test
for ExoS translocation and Pa internalization. A T-test was used to evaluate
differences in ROCK and Rac1 inhibitor studies.
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